Although the focus of inducing cell death was to evaluate changes in MHC-I expression, which would have the potential to improve CD8+ T cell recognition of cancer cells, future studies could also investigate how DTCVs could impact CD4+ T cell development, as CD4+ T cells can help promote and sustain anti-tumor CD8+ T cell responses (81). Here, CD8A is linked to cancer.